All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Azaperone | NCIT_C74187 | |
| Tomoglumide | NCIT_C74180 | |
| Amiglumide | NCIT_C74181 | |
| Girisopam | NCIT_C74182 | |
| Gedocarnil | NCIT_C74183 | |
| Aminothiazole | NCIT_C74177 | |
| Antithyroid Agent | NCIT_C885 | [A pharmacological agent that acts as a thyroid hormone antagonist. Antithyroid agents may inhibit thyroid hormone production.] |
| Crataegus azarolus | NCIT_C74178 | |
| Brometenamine | NCIT_C74179 | |
| Antitussive Agent | NCIT_C66917 | [Any substance that is capable of relieving or suppressing coughing.] |
| Carcinoma of the Lacrimal Gland pT4b TNM Finding v7 | NCIT_C88796 | [Carcinoma of the lacrimal gland with tumor invading orbital bone. (from AJCC 7th Ed.)] |
| Carcinoma of the Lacrimal Gland pT4 TNM Finding v7 | NCIT_C88794 | [Carcinoma of the lacrimal gland with tumor invading periosteum or orbital bone or adjacent structures. (from AJCC 7th Ed.)] |
| Carcinoma of the Lacrimal Gland pT4c TNM Finding v7 | NCIT_C88797 | [Carcinoma of the lacrimal gland with tumor invading adjacent structures (brain, sinus, pterygoid fossa, temporal fossa). (from AJCC 7th Ed.)] |
| Carcinoma of the Lacrimal Gland Pathologic Regional Lymph Nodes TNM Finding v7 | NCIT_C88798 | [A pathologic finding about one or more characteristics of carcinoma of the lacrimal gland, following the rules of the TNM AJCC v7 classification system as they pertain to staging of regional lymph nodes.] |
| Carcinoma of the Lacrimal Gland pNX TNM Finding v7 | NCIT_C88799 | [Carcinoma of the lacrimal gland in which the regional lymph nodes cannot be assessed. (from AJCC 7th Ed.)] |
| Antienite | NCIT_C74151 | |
| Antihelminthic Agent | NCIT_C250 | [A pharmacological agent that can kill or prevent the reproduction of parasitic helminths, including nematodes, flukes and tapeworms.] |
| Racemetirosine | NCIT_C74152 | |
| Antihypertensive Agent | NCIT_C270 | [Any substance used in the treatment of acute or chronic hypertension regardless of pharmacological mechanism. Antihypertensive agents include diuretics, alpha-adrenergic and beta-adrenergic antagonists, angiotensin-converting enzyme inhibitors, calcium channel blockers, ganglionic blockers, and vasodilator agents.] |
| Dapabutan | NCIT_C74153 |